4-Aminopyridine
Showing 1 - 25 of >10,000
Nerve Injury, Prostate Cancer Trial in Rochester (4-Aminopyridine, Placebo)
Recruiting
- Nerve Injury
- Prostate Cancer
- 4-Aminopyridine
- Placebo
-
Rochester, New York
- +1 more
May 13, 2022
Peripheral Nerve Injury, Crush Injury Trial (4-Aminopyridine, Placebo)
Not yet recruiting
- Peripheral Nerve Injury
- Crush Injury
- 4-Aminopyridine
- Placebo
- (no location specified)
Aug 18, 2023
Nerve Injury Trial in Hershey (4-Aminopyridine, Placebo oral tablet)
Terminated
- Nerve Injury
- 4-Aminopyridine
- Placebo oral tablet
-
Hershey, PennsylvaniaMS Hershey Medical Center
Oct 12, 2022
Spinal Cord Injuries, Chronic Trial in Mexico City (4-Aminopyridine, Placebo oral capsule)
Active, not recruiting
- Spinal Cord Injuries
- Chronic
- 4-Aminopyridine
- Placebo oral capsule
-
Mexico City, MexicoHospital de Especialidades, CMN Siglo XXI
Feb 18, 2021
Episodic Ataxia Type 2 Trial in Los Angeles, Tampa, Rochester (4-Aminopyridine, Placebo)
Withdrawn
- Episodic Ataxia Type 2
- 4-Aminopyridine
- Placebo
-
Los Angeles, California
- +2 more
Nov 12, 2020
Multiple Sclerosis Trial in Cairo (Dalfampridine ER, 10 Mg Oral Tablet, Extended Release, Placebo)
Recruiting
- Multiple Sclerosis
- Dalfampridine ER, 10 Mg Oral Tablet, Extended Release
- Placebo
-
Cairo, EgyptAin Shams Univeristy
Feb 15, 2023
Multiple Sclerosis Trial in Mexico City (4-aminopyridine, Placebo)
Completed
- Multiple Sclerosis
- 4-aminopyridine
- Placebo
-
Mexico City, Distrito Federal, MexicoHospital de Especialidades, CMN Siglo XXI
Aug 6, 2019
Vestibular Migraine, Migraine Disorders, Vestibular Diseases Trial in Boston (4-aminopyridine, Atenolol, Placebo)
Withdrawn
- Vestibular Migraine
- +2 more
- 4-aminopyridine
- +2 more
-
Boston, MassachusettsMassachusetts Eye and Ear Infirmary
Jan 4, 2019
Working Memory, Post-covid-19 Trial in Basel (Fampridine SR, Placebo)
Recruiting
- Working Memory
- Post-covid-19
- Fampridine SR
- Placebo
-
Basel, BS, SwitzerlandUniversity of Basel, Transfaculty Research Platform
Dec 22, 2022
Hereditary Spastic Paraplegia Trial in Nicosia (Dalfampridine 10 MG, Placebo, Physiotherapy)
Completed
- Hereditary Spastic Paraplegia
- Dalfampridine 10 MG
- +2 more
-
Nicosia, CyprusDr. Burhan Nalbantoğlu State Hospital
Nov 17, 2022
Motor Neuron Disease, Upper Trial in Gainesville, Boston, New York (dalfampridine)
Active, not recruiting
- Motor Neuron Disease, Upper
-
Gainesville, Florida
- +2 more
Mar 29, 2022
Prostate Disease Trial in Rochester (4-aminopyridine, )
Withdrawn
- Prostate Disease
- 4-aminopyridine
- placebo
-
Rochester, New YorkUniversity of Rochester Medical Center
Oct 31, 2018
Multiple Sclerosis Trial in Boston (drug, behavioral, other)
Not yet recruiting
- Multiple Sclerosis
- Dalfampridine 10 MG [Ampyra]
- +2 more
-
Boston, MassachusettsMGH Institute of Health Professions
Nov 13, 2023
Multiple Sclerosis Trial (Dalfampridine Pill, Placebo)
Completed
- Multiple Sclerosis
- Dalfampridine Pill
- Placebo
- (no location specified)
May 5, 2023
Spinal Cord Injury Trial in Chicago (drug, other, behavioral)
Recruiting
- Spinal Cord Injury
- Dalfampridine
- +3 more
-
Chicago, IllinoisShirley Ryan Abilitylab
Jul 6, 2022
Optic Neuritis Trial in London (Fampridine SR)
Recruiting
- Optic Neuritis
- Fampridine SR
-
London, Ontario, CanadaLondon Health Sciences Centre
Aug 22, 2022
Working Memory Trial in Basel (Fampridine SR, Placebo)
Recruiting
- Working Memory
- Fampridine SR
- Placebo
-
Basel, BS, SwitzerlandUniversity of Basel, Transfaculty Research Platform
Apr 19, 2022
Multiple Sclerosis Trial in Odense C (Fampridine)
Completed
- Multiple Sclerosis
-
Odense C, DenmarkUniversity of Southern Denmark - Odense Univarsity Hospital
Mar 31, 2022
Endometrial Serous Adenocarcinoma Trial in United States (Biospecimen Collection, Resection, Triapine)
Recruiting
- Endometrial Serous Adenocarcinoma
- Biospecimen Collection
- +2 more
-
Coral Gables, Florida
- +5 more
Aug 23, 2022
Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Dublin (Fampridine, Placebo)
Completed
- Secondary Progressive Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
- Fampridine
- Placebo
-
Dublin, Dublin 4, Ireland
- +1 more
Jul 8, 2021
Metastatic Digestive System Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in United States (Lutetium Lu 177
Recruiting
- Metastatic Digestive System Neuroendocrine Neoplasm
- Metastatic Neuroendocrine Tumor
- Lutetium Lu 177 Dotatate
- Triapine
-
Phoenix, Arizona
- +10 more
Aug 23, 2022
Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma, Advanced Cervical Squamous Cell Carcinoma Trial in
Recruiting
- Advanced Cervical Adenocarcinoma
- +12 more
- Biospecimen Collection
- +11 more
-
Los Angeles, California
- +15 more
Aug 23, 2022
Working Memory Trial in Basel (Fampridine SR, Placebo)
Withdrawn
- Working Memory
- Fampridine SR
- Placebo
-
Basel, BS, SwitzerlandUniversity of Basel, Transfaculty Research Platform
Oct 13, 2020
Walking Impairment, Multiple Sclerosis Trial in Canada, United States (ADS-5102, 137 mg, ADS-5102, 274 mg, Placebo)
Completed
- Walking Impairment
- Multiple Sclerosis
- ADS-5102, 137 mg
- +2 more
-
Cullman, Alabama
- +83 more
Dec 19, 2021
Multiple Sclerosis, Optic Neuritis Trial in Saint Louis (Dalfampridine/Placebo, Placebo/Dalfampridine)
Completed
- Multiple Sclerosis
- Optic Neuritis
- Dalfampridine/Placebo
- Placebo/Dalfampridine
-
Saint Louis, MissouriWashington University (John L. Trotter MS Center)
Jan 23, 2020